Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,163
Closed -$883K 2822
2016
Q4
$883K Sell
1,163
-1,941
-63% -$1.47M ﹤0.01% 1337
2016
Q3
$2.55M Buy
3,104
+2,135
+220% +$1.85M 0.01% 817
2016
Q2
$806K Buy
+969
New +$809K ﹤0.01% 1224
2016
Q1
Sell
-3,181
Closed -$3.28M 2762
2015
Q4
$3.28M Buy
3,181
+2,509
+373% +$2.52M 0.02% 643
2015
Q3
$634K Sell
672
-784
-54% -$818K ﹤0.01% 1406
2015
Q2
$1.52M Buy
+1,456
New +$1.52M 0.01% 1048

Other funds holding AGN.PRA

Jefferies Group's AGN.PRA Position: Q1 2017 in Review

Jefferies Group sold out of Allergan plc (AGN.PRA) in Q1 2017, closing a stake of 1,163 shares — an estimated $883K sold.

Jefferies Group first reported a position in AGN.PRA in Q2 2015 and held it in 6 quarters. The position peaked at $3.28M in Q4 2015. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2017.

  • Jefferies Group reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Jefferies Group sold 1,163 Allergan plc shares in Q1 2017, an estimated $883K.
  • Jefferies Group first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
  • Jefferies Group's Allergan plc position peaked at $3.28M in Q4 2015.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Jefferies Group's 13F filing for Q1 2017, filed 15 May 2017.